Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.

Avezum Á, Oliveira GBF, Oliveira H, Lucchetta RC, Pereira VFA, Dabarian AL, D O Vieira R, Silva DV, Kormann APM, Tognon AP, De Gasperi R, Hernandes ME, Feitosa ADM, Piscopo A, Souza AS, Miguel CH, Nogueira VO, Minelli C, Magalhães CC, Morejon KML, Bicudo LS, Souza GEC, Gomes MAM, Fo JJFR, Schwarzbold AV, Zilli A, Amazonas RB, Moreira FR, Alves LBO, Assis SRL, Neves PDMM, Matuoka JY, Boszczowski I, Catarino DGM, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Cavalcanti AB, Berwanger O, COPE - COALITION COVID-19 Brazil V Investigators

Open source

DOI
10.1016/j.lana.2022.100243
Published
2022 Jul
Container
Lancet regional health. Americas
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lana.2022.100243,
  title = {Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.},
  author = {Avezum Á and Oliveira GBF and Oliveira H and Lucchetta RC and Pereira VFA and Dabarian AL and D O Vieira R and Silva DV and Kormann APM and Tognon AP and De Gasperi R and Hernandes ME and Feitosa ADM and Piscopo A and Souza AS and Miguel CH and Nogueira VO and Minelli C and Magalhães CC and Morejon KML and Bicudo LS and Souza GEC and Gomes MAM and Fo JJFR and Schwarzbold AV and Zilli A and Amazonas RB and Moreira FR and Alves LBO and Assis SRL and Neves PDMM and Matuoka JY and Boszczowski I and Catarino DGM and Veiga VC and Azevedo LCP and Rosa RG and Lopes RD and Cavalcanti AB and Berwanger O and COPE - COALITION COVID-19 Brazil V Investigators},
  year = {2022},
  journal = {Lancet regional health. Americas},
  doi = {10.1016/j.lana.2022.100243},
  url = {https://doi.org/10.1016/j.lana.2022.100243}
}

RIS

TY  - JOUR
TI  - Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.
AU  - Avezum Á
AU  - Oliveira GBF
AU  - Oliveira H
AU  - Lucchetta RC
AU  - Pereira VFA
AU  - Dabarian AL
AU  - D O Vieira R
AU  - Silva DV
AU  - Kormann APM
AU  - Tognon AP
AU  - De Gasperi R
AU  - Hernandes ME
AU  - Feitosa ADM
AU  - Piscopo A
AU  - Souza AS
AU  - Miguel CH
AU  - Nogueira VO
AU  - Minelli C
AU  - Magalhães CC
AU  - Morejon KML
AU  - Bicudo LS
AU  - Souza GEC
AU  - Gomes MAM
AU  - Fo JJFR
AU  - Schwarzbold AV
AU  - Zilli A
AU  - Amazonas RB
AU  - Moreira FR
AU  - Alves LBO
AU  - Assis SRL
AU  - Neves PDMM
AU  - Matuoka JY
AU  - Boszczowski I
AU  - Catarino DGM
AU  - Veiga VC
AU  - Azevedo LCP
AU  - Rosa RG
AU  - Lopes RD
AU  - Cavalcanti AB
AU  - Berwanger O
AU  - COPE - COALITION COVID-19 Brazil V Investigators
PY  - 2022
JO  - Lancet regional health. Americas
DO  - 10.1016/j.lana.2022.100243
UR  - https://doi.org/10.1016/j.lana.2022.100243
ER  -

APA

Á, A., GBF, O., H, O., RC, L., VFA, P., AL, D., R, D. O. V., DV, S., APM, K., AP, T., R, D. G., ME, H., ADM, F., A, P., AS, S., CH, M., VO, N., C, M., CC, M., KML, M., LS, B., GEC, S., MAM, G., JJFR, F., AV, S., A, Z., RB, A., FR, M., LBO, A., SRL, A., PDMM, N., JY, M., I, B., DGM, C., VC, V., LCP, A., RG, R., RD, L., AB, C., O, B., & Investigators, C. -. C. C. B. V. (2022). Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.. Lancet regional health. Americas. https://doi.org/10.1016/j.lana.2022.100243

Source records